Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (23632) 23632
Publication (1475) 1475
Newsletter (957) 957
Book Review (150) 150
Book / eBook (107) 107
Book Chapter (101) 101
Conference Proceeding (73) 73
Magazine Article (22) 22
Dissertation (19) 19
Government Document (5) 5
Newspaper Article (3) 3
Web Resource (3) 3
Reference (2) 2
Trade Publication Article (2) 2
Transcript (2) 2
Data Set (1) 1
Journal / eJournal (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
animals (13100) 13100
humans (6662) 6662
male (6510) 6510
amines (6506) 6506
rats (6310) 6310
index medicus (4948) 4948
pharmacology & pharmacy (4573) 4573
amines - pharmacology (3652) 3652
female (3214) 3214
mice (3027) 3027
chemistry, medicinal (2448) 2448
biochemistry & molecular biology (1950) 1950
amines - chemistry (1909) 1909
kinetics (1849) 1849
structure-activity relationship (1756) 1756
neurosciences (1720) 1720
biogenic amines (1683) 1683
in vitro techniques (1598) 1598
dose-response relationship, drug (1580) 1580
biogenic amines - metabolism (1571) 1571
research (1522) 1522
time factors (1453) 1453
toxicology (1400) 1400
drugs (1364) 1364
brain - metabolism (1328) 1328
amines - metabolism (1327) 1327
organic compounds (1313) 1313
chemistry (1298) 1298
analysis (1273) 1273
chemistry, multidisciplinary (1199) 1199
dopamine (1170) 1170
rats, inbred strains (1143) 1143
molecular structure (1127) 1127
pharmacology (1113) 1113
serotonin - metabolism (1099) 1099
serotonin (1098) 1098
proteins (1078) 1078
brain (1027) 1027
chemistry, organic (1019) 1019
dopamine - metabolism (1013) 1013
adult (994) 994
gabapentin (950) 950
rats, sprague-dawley (910) 910
brain - drug effects (903) 903
amines - chemical synthesis (901) 901
rodents (895) 895
enzymes (878) 878
norepinephrine - metabolism (868) 868
metabolism (861) 861
hydrogen-ion concentration (830) 830
mammals (819) 819
amine oxidase (775) 775
chemical phenomena (767) 767
middle aged (762) 762
rabbits (747) 747
receptors (745) 745
basic biological sciences (731) 731
derivatives (731) 731
rats, wistar (728) 728
vertebrates (717) 717
article (693) 693
research article (671) 671
inhibition (658) 658
cell biology (656) 656
oxidation-reduction (656) 656
amine oxidase - metabolism (650) 650
cell line (650) 650
heterocyclic compounds (640) 640
cells, cultured (636) 636
biochemistry (635) 635
brain chemistry - drug effects (621) 621
guinea pigs (618) 618
physiological aspects (614) 614
cancer (612) 612
cattle (602) 602
physiology (601) 601
organic nitrogen compounds (594) 594
multidisciplinary sciences (592) 592
body (588) 588
psychiatry (588) 588
behavior, animal - drug effects (586) 586
in-vitro (579) 579
chromatography, high pressure liquid (561) 561
binding sites (560) 560
amino acids (554) 554
rat (553) 553
amines - therapeutic use (552) 552
ligands (549) 549
organs (538) 538
dogs (537) 537
cyclohexanecarboxylic acids (528) 528
gamma-aminobutyric acid - pharmacology (524) 524
norepinephrine (524) 524
cell line, tumor (522) 522
monoamine oxidase inhibitors - pharmacology (511) 511
serotonin - pharmacology (509) 509
magnetic resonance spectroscopy (503) 503
toxicity (503) 503
clinical neurology (499) 499
monoamine oxidase - metabolism (497) 497
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (77) 77
UofT at Mississauga - Stacks (10) 10
UofT at Scarborough - Stacks (6) 6
Collection Dvlpm't (Acquisitions) - Closed Orders (5) 5
UTL at Downsview - May be requested (5) 5
Collection Dvlpm't (Acquisitions) - Vendor file (4) 4
Earth Sciences (Noranda) - Stacks (4) 4
Online Resources - Online (4) 4
Chemistry (A D Allen) - Stacks (3) 3
Gerstein Science - Periodical Stacks (3) 3
Collection Dvlpm't (Acquisitions) - Cancelled Order (2) 2
Chemistry (A D Allen) - May be requested in 6-10 wks (1) 1
Chemistry (A D Allen) - Reference (1) 1
Engineering & Comp. Sci. - May be requested in 6-10 wks (1) 1
Engineering & Comp. Sci. - Reference (1) 1
Engineering & Comp. Sci. - Stacks (1) 1
Gerstein Science - Not Returned (1) 1
Gerstein Science - Theses (1) 1
Law (Bora Laskin) - Stacks (1) 1
Royal Ontario Museum - Stacks (1) 1
St Josephs Health Centre - Stacks (1) 1
University Archives - Archives (1) 1
UofT at Mississauga - Reference (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (22709) 22709
German (802) 802
Japanese (392) 392
Russian (343) 343
French (217) 217
Italian (98) 98
Spanish (84) 84
Polish (83) 83
Chinese (65) 65
Portuguese (20) 20
Ukrainian (14) 14
Dutch (10) 10
Slovak (8) 8
Bulgarian (7) 7
Czech (7) 7
Hungarian (5) 5
Croatian (4) 4
Romanian (3) 3
Swedish (2) 2
Arabic (1) 1
Norwegian (1) 1
Serbian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Model-based Drug Development
by Lalonde, R L and Kowalski, K G and Hutmacher, M M and Ewy, W and Nichols, D J and Milligan, P A and Corrigan, B W and Lockwood, P A and Marshall, S A and Benincosa, L J and Tensfeldt, T G and Parivar, K and Amantea, M and Glue, P and Koide, H and Miller, R
Clinical Pharmacology & Therapeutics, ISSN 0009-9236, 07/2007, Volume 82, Issue 1, pp. 21 - 32
The low productivity and escalating costs of drug development have been well documented over the past several years. Less than 10% of new compounds that enter... 
TRIPTANS SEROTONIN | METAANALYSIS | PAIN | DOSE-RESPONSE | INTEGRATION | 5-HT1B/1D AGONISTS | CLINICAL-TRIALS | DISEASE | PHARMACOLOGY & PHARMACY | SIMULATION | MIGRAINE | Analgesics - pharmacology | Muscarinic Agonists - pharmacology | Cholesterol - blood | Humans | Glycoproteins - pharmacology | Caproates - therapeutic use | Amines - therapeutic use | Alzheimer Disease - psychology | Neutrophil Infiltration - drug effects | United States Food and Drug Administration | Glycoproteins - therapeutic use | Alzheimer Disease - drug therapy | gamma-Aminobutyric Acid - pharmacology | Stroke - drug therapy | Cognition - drug effects | Bridged Bicyclo Compounds, Heterocyclic - pharmacology | Hydroxymethylglutaryl-CoA Reductase Inhibitors - pharmacology | Models, Biological | Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use | Amines - pharmacology | Immunologic Factors - pharmacology | Clinical Trials as Topic - legislation & jurisprudence | Guidelines as Topic | Meta-Analysis as Topic | Clinical Trials as Topic - statistics & numerical data | United States | Caproates - pharmacology | Muscarinic Agonists - therapeutic use | Oximes - therapeutic use | Drug Approval | Hypercholesterolemia - drug therapy | Dose-Response Relationship, Drug | Bridged Bicyclo Compounds, Heterocyclic - therapeutic use | Computer Simulation | Drug Design | gamma-Aminobutyric Acid - therapeutic use | Stroke - immunology | Analgesics - therapeutic use | Cyclohexanecarboxylic Acids - therapeutic use | Hypercholesterolemia - blood | Reproducibility of Results | Neuralgia, Postherpetic - drug therapy | Pharmacology | Models, Statistical | Animals | Anticholesteremic Agents - therapeutic use | Cyclohexanecarboxylic Acids - pharmacology | Oximes - pharmacology | Clinical Trials as Topic - methods | Pharmacokinetics | Research Design | Anticholesteremic Agents - pharmacology | Immunologic Factors - therapeutic use
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Inhibition of monoamine oxidase activity by antidepressants and mood stabilizers
by Fišar, Zdeněk and Hroudová, Jana and Raboch, Jiří
Neuroendocrinology Letters, ISSN 0172-780X, 2010, Volume 31, Issue 5, pp. 645 - 656
OBJECTIVE: Monoamine oxidase (MAO), the enzyme responsible for metabolism of monoamine neurotransmitters, has an important role in the brain development and... 
Mood stabilizers | Monoamine oxidase inhibitors | Antidepressive agents | RAT-LIVER | antidepressive agents | monoamine oxidase inhibitors | FRONTAL-CORTEX | REUPTAKE INHIBITORS | MAJOR DEPRESSION | HUMAN PLATELET | mood stabilizers | NEUROSCIENCES | TRICYCLIC ANTIDEPRESSANTS | MONO-AMINE OXIDASE | ENDOCRINOLOGY & METABOLISM | MAO INHIBITORS | REVERSIBLE INHIBITORS | PARKINSONS-DISEASE | Mitochondria - enzymology | Citalopram - pharmacology | Clorgyline - pharmacology | Monoamine Oxidase - drug effects | Cerebral Cortex - cytology | Valproic Acid - pharmacology | Mianserin - analogs & derivatives | Mianserin - pharmacology | Desipramine - pharmacology | Swine | Antidepressive Agents - pharmacology | Cyclohexanols - pharmacology | Moclobemide - pharmacology | Fluoxetine - pharmacology | Monoamine Oxidase Inhibitors - pharmacology | Affect - drug effects | Benzodiazepines - pharmacology | Antimanic Agents - pharmacology | Lithium - pharmacology | Morpholines - pharmacology | Thiazepines - pharmacology | Mitochondria - drug effects | Iproniazid - pharmacology | Venlafaxine Hydrochloride | Cocaine - pharmacology | Animals | Pargyline - pharmacology | Amitriptyline - pharmacology | Imipramine - pharmacology | In Vitro Techniques | Monoamine Oxidase - metabolism
Journal Article
Details down arrow
3. Full Text Astrocyte-derived thrombospondins mediate the development of hippocampal presynaptic plasticity in vitro
by Crawford, Devon C and Jiang, Xiaoping and Taylor, Amanda and Mennerick, Steven
Journal of Neuroscience, ISSN 0270-6474, 09/2012, Volume 32, Issue 38, pp. 13100 - 13110
Astrocytes contribute to many neuronal functions, including synaptogenesis, but their role in the development of synaptic plasticity remains unclear.... 
NEUROPATHIC PAIN | PYRAMIDAL CELLS | PROTEIN-KINASE | NECROSIS-FACTOR-ALPHA | SILENT SYNAPSES | ANTIEPILEPTIC DRUGS | GABAPENTIN | DIFFERENTIAL REGULATION | NEUROSCIENCES | CALCIUM-CHANNEL | GLIAL TNF-ALPHA | Electric Stimulation | Coculture Techniques | Culture Media, Conditioned - chemistry | Neuronal Plasticity - drug effects | Culture Media, Conditioned - pharmacology | Male | Excitatory Postsynaptic Potentials - drug effects | N-Methylaspartate - pharmacology | Thrombospondins - pharmacology | Quinoxalines - pharmacology | CREB-Binding Protein - metabolism | Cyclic AMP - analogs & derivatives | Potassium Chloride - pharmacology | Statistics, Nonparametric | Female | Phosphorylation - drug effects | Hippocampus - growth & development | Organ Culture Techniques | Receptors, AMPA - metabolism | Animals, Newborn | Synapses - drug effects | Presynaptic Terminals - drug effects | Vesicular Glutamate Transport Protein 1 - metabolism | Valine - analogs & derivatives | Rats | gamma-Aminobutyric Acid - pharmacology | Excitatory Amino Acid Agonists - pharmacology | Excitatory Amino Acid Antagonists - pharmacology | Adenosine - pharmacology | Biophysics | Thionucleotides - pharmacology | Hippocampus - cytology | Rats, Sprague-Dawley | Cyclic AMP - pharmacology | Nerve Tissue Proteins - metabolism | Astrocytes - physiology | Patch-Clamp Techniques | Animals | Cyclohexanecarboxylic Acids - pharmacology | Adenosine - analogs & derivatives | Dynamin I - metabolism | Protein Kinase Inhibitors - pharmacology | Valine - pharmacology | Amines - pharmacology | Thrombospondins - metabolism
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Effects of antiepileptic drugs on GABA release from rat and human neocortical synaptosomes
by Kammerer, M and Rassner, M P and Freiman, T M and Feuerstein, T J
Naunyn-Schmiedeberg's Archives of Pharmacology, ISSN 0028-1298, 7/2011, Volume 384, Issue 1, pp. 47 - 57
In epilepsy, allegedly, a neurotransmitter imbalance between the inhibitory GABA and the excitatory glutamate prevails. Therefore, some antiepileptic drugs... 
Neurosciences | Veratridine | Biomedicine | Epilepsy | GABA | Neocortical synaptosomes | Pharmacology/Toxicology | Antiepileptic drugs | Potassium | ACTION-POTENTIALS | VOLTAGE-DEPENDENT LIMITATION | TEMPORAL-LOBE EPILEPSY | NEUROTRANSMITTER RELEASE | VALPROIC ACID | TRANSPORTER GAT-1 | MOUSE CENTRAL NEURONS | IN-VITRO | SODIUM VALPROATE | PHARMACOLOGY & PHARMACY | CALCIUM-CHANNEL | Synaptosomes - drug effects | Rats, Wistar | gamma-Aminobutyric Acid - metabolism | Humans | Middle Aged | Child, Preschool | Infant | Male | Pregabalin | Synaptosomes - metabolism | Anticonvulsants - pharmacology | Valproic Acid - pharmacology | Calcium - deficiency | Young Adult | Calcium - antagonists & inhibitors | Neocortex - metabolism | Neocortex - drug effects | Piracetam - pharmacology | Adult | Female | Phenytoin - pharmacology | Tetrodotoxin - pharmacology | Nipecotic Acids - pharmacology | Child | Carbamazepine - pharmacology | Triazines - pharmacology | Rats | gamma-Aminobutyric Acid - pharmacology | Tetanus Toxin - pharmacology | Potassium - pharmacology | Veratridine - pharmacology | GABA Antagonists - pharmacology | Animals | Cyclohexanecarboxylic Acids - pharmacology | Piracetam - analogs & derivatives | Adolescent | Oximes - pharmacology | Aged | gamma-Aminobutyric Acid - analogs & derivatives | Amines - pharmacology | Phenytoin - pharmacokinetics | Drugs | Brain | Anticonvulsants | Marine toxins | Neurons | Tetanus | Glutamate | Sodium channels | gamma -Aminobutyric acid | Calcium | lamotrigine | Cortex | veratridine | tetanus toxin | Antiepileptic agents | Exocytosis | Valproic acid | Etiracetam | Carbamazepine | Depolarization | Neurotransmitters | Neural networks | gabapentin | Synaptosomes | Phenytoin
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Monoamine transporter and receptor interaction profiles of a new series of designer cathinones
by Simmler, L.D and Rickli, A and Hoener, M.C and Liechti, M.E
Neuropharmacology, ISSN 0028-3908, 04/2014, Volume 79, pp. 152 - 160
Psychoactive β-keto amphetamines (cathinones) are sold as “bath salts” or “legal highs” and recreationally abused. We characterized the pharmacology of a new... 
Bath salts | Norepinephrine | Dopamine | Serotonin | Transporter | 5-HT RELEASE | 3,4-METHYLENEDIOXYPYROVALERONE MDPV | HUMAN DOPAMINE | NEUROSCIENCES | SEROTONIN TRANSPORTERS | PSYCHOACTIVE SUBSTANCES | IN-VITRO | BRAIN-TISSUE | PHARMACOLOGY & PHARMACY | METHCATHINONE ANALOGS | PARA-METHOXYAMPHETAMINE | Designer Drugs - pharmacology | Dopamine Uptake Inhibitors - pharmacology | Amphetamines - pharmacology | Humans | Propiophenones - pharmacology | Plasma Membrane Neurotransmitter Transport Proteins - antagonists & inhibitors | Plasma Membrane Neurotransmitter Transport Proteins - metabolism | Receptors, Biogenic Amine - antagonists & inhibitors | Butyrophenones - pharmacology | HEK293 Cells | Pentanones - pharmacology | Receptors, Biogenic Amine - metabolism | Adrenergic Uptake Inhibitors - pharmacology | Biogenic Monoamines - metabolism | Serotonin Uptake Inhibitors - pharmacology | Methylamines - pharmacology | Cytokinins | Polymethylmethacrylate | Bath products | Ecstasy (Drug) | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Small artery remodeling depends on tissue-type transglutaminase
by Bakker, Erik N. T. P and Buus, Carsten L and Spaan, Jos A. E and Perree, Jop and Ganga, Anuradha and Rolf, Titia M and Sorop, Oana and Bramsen, Linda H and Mulvany, Michael J and VanBavel, Ed
Circulation research, ISSN 0009-7330, 2005, Volume 96, Issue 1, pp. 119 - 126
Remodeling of small arteries is essential in the long-term regulation of blood pressure and blood flow to specific organs or tissues. A large part of the... 
Vascular remodeling | Tissue transglutaminase | Vasoconstriction | Blood flow | INDUCED ACTIVATION | APOPTOSIS | CARDIAC & CARDIOVASCULAR SYSTEMS | RESISTANCE ARTERIES | CROSS-LINKING | SPASM | tissue transglutaminase | vascular remodeling | FLOW | STRUCTURAL-CHANGES | ADAPTATION | PERIPHERAL VASCULAR DISEASE | vasoconstriction | HYPERTENSION | HEMATOLOGY | blood flow | Norepinephrine - pharmacology | GTP-Binding Proteins - pharmacology | Mesenteric Arteries - physiology | Cross-Linking Reagents - pharmacology | Endothelin-1 - pharmacology | Transglutaminases - pharmacology | Transglutaminases - genetics | Nitroprusside - pharmacology | Hemorheology | Cadaverine - pharmacology | GTP-Binding Proteins - genetics | Vasoconstriction - physiology | Enzyme Induction - drug effects | Cystamine - pharmacology | Female | Nitric Oxide Donors - pharmacology | Myocytes, Smooth Muscle - cytology | Organ Culture Techniques | Muscle, Skeletal - blood supply | Tretinoin - pharmacology | Vasoconstrictor Agents - pharmacology | Extracellular Matrix Proteins - chemistry | GTP-Binding Proteins - physiology | Guinea Pigs | Vasodilator Agents - pharmacology | Gels | Cell Size - drug effects | Transglutaminases - biosynthesis | Rats | Nitric Oxide - physiology | Papaverine - pharmacology | Arteries - drug effects | Vasoconstriction - drug effects | Extracellular Matrix Proteins - drug effects | Extracellular Matrix - ultrastructure | Animals | Arteries - enzymology | Coronary Vessels - cytology | Vasomotor System - physiology | Collagen | Biotin - pharmacology | Transglutaminases - physiology | GTP-Binding Proteins - biosynthesis | Amines - pharmacology | Mesenteric Arteries - enzymology | Sus scrofa | Biotin - analogs & derivatives
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Sexual behavior
: pharmacology and biochemistry
by Gessa, G. L and Sandler, Merton
1975, ISBN 9780890040058, ix, 354
Sex (Biology) | Neuroendocrinology | Sexual disorders | Psychopharmacology
Book
Details down arrow
8. Full Text Pharmacological and pharmacokinetic characterization of the cannabinoid receptor 2 agonist, GW405833, utilizing rodent models of acute and chronic pain, anxiety, ataxia and catalepsy
by Valenzano, Kenneth J and Tafesse, Laykea and Lee, Gary and Harrison, James E and Boulet, Jamie M and Gottshall, Susan L and Mark, Lilly and Pearson, Michelle S and Miller, Wendy and Shan, Shen and Rabadi, Leyana and Rotshteyn, Yakov and Chaffer, Suzanne M and Turchin, Paul I and Elsemore, David A and Toth, Mathew and Koetzner, Lee and Whiteside, Garth T
Neuropharmacology, ISSN 0028-3908, 2005, Volume 48, Issue 5, pp. 658 - 672
To date, two cannabinoid receptors have been identified, CB1 and CB2. Activation of these receptors with non-selective cannabinoid receptor agonists reduces... 
CB2 | Rotarod | GW405833 | Radioligand binding | Incisional pain | Catalepsy | Anxiety | Cannabinoid | Pharmacokinetics | Inflammatory pain | Neuropathic pain | ACTIVATION | ANTIHYPERALGESIC ACTIVITY | MICE DEFICIENT | cannabinoid | radioligand binding | NEUROSCIENCES | RAT MODEL | incisional pain | catalepsy | anxiety | CB2 RECEPTORS | neuropathic pain | INHIBITION | pharmacokinetics | inflammatory pain | PHARMACOLOGY & PHARMACY | rotarod | EXPRESSION | CANNABINOIDS | Analgesics - pharmacology | Cricetulus | Receptor, Cannabinoid, CB2 - agonists | Humans | Catalepsy - metabolism | Male | Benzoxazines | Pain - metabolism | Anti-Inflammatory Agents, Non-Steroidal - pharmacology | Dose-Response Relationship, Drug | Time Factors | Inflammation - drug therapy | Reaction Time - drug effects | Behavior, Animal - drug effects | Indoles - pharmacology | Cyclohexanols - pharmacology | Anxiety - metabolism | Ataxia - metabolism | Cyclic AMP - metabolism | Immunosuppressive Agents - pharmacology | CHO Cells | Disease Models, Animal | Cricetinae | Morpholines - pharmacology | Rats | gamma-Aminobutyric Acid - pharmacology | Excitatory Amino Acid Antagonists - pharmacology | Psychomotor Performance - drug effects | Rats, Sprague-Dawley | Indomethacin - pharmacology | Mice, Knockout | Naphthalenes - pharmacology | Binding, Competitive - drug effects | Receptor, Cannabinoid, CB2 - metabolism | Pain Measurement - methods | Animals | Cyclohexanecarboxylic Acids - pharmacology | Indoles - pharmacokinetics | Mice | Morpholines - pharmacokinetics | Amines - pharmacology | Receptor, Cannabinoid, CB2 - deficiency | Care and treatment | Pain | Analysis | Physiological aspects | Ataxia | Models | Chemical properties
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text The VMAT-2 inhibitor tetrabenazine affects effort-related decision making in a progressive ratio/chow feeding choice task: Reversal with antidepressant drugs
by Randall, Patrick A and Lee, Christie A and Nunes, Eric J and Yohn, Samantha E and Nowak, Victoria and Khan, Bilal and Shah, Priya and Pandit, Saagar and Vemuri, V. Kiran and Makriyannis, Alex and Baqi, Younis and Müller, Christa E and Correa, Merce and Salamone, John D
PLoS ONE, ISSN 1932-6203, 06/2014, Volume 9, Issue 6, p. e99320
Behavioral activation is a fundamental feature of motivation, and organisms frequently make effort-related decisions based upon evaluations of reinforcement... 
MOVEMENT-DISORDERS | ADENOSINE A(2A) | CATECHOL-O-METHYLTRANSFERASE | A(2A) RECEPTOR ANTAGONISM | FOOD-SEEKING BEHAVIOR | NUCLEUS-ACCUMBENS DOPAMINE | NEGATIVE SYMPTOMS | MULTIDISCIPLINARY SCIENCES | MAJOR DEPRESSIVE DISORDER | ALTER RESPONSE ALLOCATION | PARKINSONS-DISEASE | Drugs | Animal models | Parkinsons disease | Schizophrenia | Antagonists | Haloperidol | Mental depression | Mental retardation | Bupropion | Motivation | Reinforcement | Behavior | Dopamine D2 receptors | Selegiline | Carbohydrates | Adenosine | Dopamine | Decision making | Rats | Fatigue | Cannabinoid CB1 receptors | Tetrabenazine | Catecholamine | Amine oxidase (flavin-containing) | Feeding | Studies | Animals | Dopamine D1 receptors | Inhibitors
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text Permeability Analysis of Neuroactive Drugs Through a Dynamic Microfluidic In Vitro Blood–Brain Barrier Model
by Booth, R and Kim, H
Annals of Biomedical Engineering, ISSN 0090-6964, 12/2014, Volume 42, Issue 12, pp. 2379 - 2391
This paper presents the permeability analysis of neuroactive drugs and correlation with in vivo brain/plasma ratios in a dynamic microfluidic blood–brain... 
Biomedical Engineering | Biochemistry, general | Microsystems | μ BBB | Biomedicine | BBB | Central nervous system | Mechanics | Biophysics and Biological Physics | Drug discovery | Biomedicine general | Endothelial cells | μBBB | VIVO | ENGINEERING, BIOMEDICAL | NEUROVASCULAR UNIT | PENETRATION | mu BBB | MASS-SPECTROMETRY | LC-MS/MS | PLASMA | SHEAR-STRESS | ENDOTHELIAL-CELLS | VARENICLINE | L-Lactate Dehydrogenase - metabolism | Coculture Techniques | Varenicline | Quinoxalines - pharmacology | Biological Transport | Piperidines - pharmacology | Indoles - pharmacology | Microfluidic Analytical Techniques | Cell Survival - drug effects | Sertraline - pharmacology | Endothelial Cells - metabolism | Valine - analogs & derivatives | Cells, Cultured | Rats | gamma-Aminobutyric Acid - pharmacology | Benzazepines - pharmacology | Permeability | Rats, Sprague-Dawley | Blood-Brain Barrier - metabolism | Pyrroles - pharmacology | Animals | Cyclohexanecarboxylic Acids - pharmacology | Tetrahydronaphthalenes - pharmacology | Neuroglia - metabolism | Mice | Valine - pharmacology | Amines - pharmacology | Ethosuximide - pharmacology | Drugs | Analysis | Microfluidics | Surgical implants | Biomedical materials | Dynamics | In vivo tests | Mathematical models
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Full Text Perioperative gabapentin improves patient-centered outcomes after inguinal hernia repair
by Quail, Jacob and Spence, Dennis and Hannon, Matthew
Military Medicine, ISSN 0026-4075, 11/2017, Volume 182, Issue 11, pp. e2052 - e2055
Introduction: Over 5,300 inguinal hernia repairs (IHR) were performed in the Military Health System in 2015. Chronic pain can be a debilitating complication,... 
MEDICINE, GENERAL & INTERNAL | QUALITY-OF-LIFE | HERNIORRHAPHY | POSTOPERATIVE PAIN | Lidocaine - pharmacology | Adjuvants, Anesthesia - pharmacology | Ondansetron - pharmacology | Adjuvants, Anesthesia - therapeutic use | Fentanyl - therapeutic use | Humans | Middle Aged | Calcium Channel Blockers - therapeutic use | Propofol - pharmacology | Lidocaine - therapeutic use | Male | Fentanyl - pharmacology | Hernia, Inguinal - drug therapy | Hypnotics and Sedatives - therapeutic use | Anesthetics, Local - pharmacology | Placebos - therapeutic use | Hernia, Inguinal - surgery | Antiemetics - therapeutic use | Amines - therapeutic use | Midazolam - therapeutic use | Adult | Androstanols - therapeutic use | Female | Anesthetics, Local - therapeutic use | Neuromuscular Depolarizing Agents - therapeutic use | Quality of Life - psychology | Succinylcholine - pharmacology | gamma-Aminobutyric Acid - therapeutic use | Neuromuscular Depolarizing Agents - pharmacology | Succinylcholine - therapeutic use | Cyclohexanecarboxylic Acids - therapeutic use | Double-Blind Method | Reconstructive Surgical Procedures - methods | gamma-Aminobutyric Acid - pharmacology | Treatment Outcome | Androstanols - pharmacology | Cyclohexanecarboxylic Acids - pharmacology | Ondansetron - therapeutic use | Hypnotics and Sedatives - pharmacology | Amines - pharmacology | Midazolam - pharmacology | Propofol - therapeutic use | Antiemetics - pharmacology | Cholecystectomy | Laparoscopy | FDA approval | Patients | Bone surgery | Quality of life | Studies | Airway management | Pain | Analgesics | Hernias | Surgeons | Anesthesia | Drug dosages
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
12. Full Text The nitric oxide-cyclic GMP-protein kinase G-K + channel pathway participates in the antiallodynic effect of spinal gabapentin
by Mixcoatl-Zecuatl, Teresa and Flores-Murrieta, Francisco J and Granados-Soto, Vinicio
European Journal of Pharmacology, ISSN 0014-2999, 2006, Volume 531, Issue 1, pp. 87 - 95
The possible participation of the nitric oxide (NO)-cyclic GMP-protein kinase G (PKG) pathway on gabapentin-induced spinal antiallodynic activity was assessed... 
Pinacidil | Gabapentin | Nitric oxide | Protein kinase G | Diazoxide | Guanylyl cyclase | K + channel opener | Neuropathic pain | channel opener | SENSITIVE POTASSIUM CHANNELS | nitric oxide | TACTILE ALLODYNIA | K+ channel opener | RANDOMIZED CONTROLLED-TRIAL | NERVE INJURY | VASCULAR SMOOTH-MUSCLE | guanylyl cyclase | neuropathic pain | gabapentin | diazoxide | pinacidil | RABBIT VENTRICULAR MYOCYTES | PHARMACOLOGY & PHARMACY | protein kinase G | UP-REGULATION | CALCIUM-CHANNEL | PERIPHERAL ANTINOCICEPTIVE ACTION | Analgesics - pharmacology | Okadaic Acid - pharmacology | Potassium Channels - physiology | Pinacidil - administration & dosage | Cyclic GMP-Dependent Protein Kinases - antagonists & inhibitors | Glyburide - pharmacology | Time Factors | Charybdotoxin - pharmacology | Oxadiazoles - pharmacology | Potassium Channel Blockers - pharmacology | Spinal Nerves - injuries | Spinal Nerves - physiopathology | Enzyme Inhibitors - pharmacology | Cyclohexanecarboxylic Acids - administration & dosage | Rats | gamma-Aminobutyric Acid - pharmacology | Indazoles - pharmacology | NG-Nitroarginine Methyl Ester - chemistry | Cyclic GMP - metabolism | Signal Transduction - drug effects | Pain - physiopathology | Nitric Oxide Synthase - metabolism | Carbazoles - pharmacology | Amines - pharmacology | Diazoxide - administration & dosage | Cyclic GMP - antagonists & inhibitors | Diazoxide - pharmacology | Rats, Wistar | Stereoisomerism | Nitric Oxide Synthase - antagonists & inhibitors | gamma-Aminobutyric Acid - administration & dosage | Apamin - pharmacology | Cyclic GMP-Dependent Protein Kinases - metabolism | Dose-Response Relationship, Drug | Quinoxalines - pharmacology | Amines - administration & dosage | Female | Indoles - pharmacology | Injections, Spinal | NG-Nitroarginine Methyl Ester - pharmacology | Pinacidil - pharmacology | Vasodilator Agents - pharmacology | Pain - prevention & control | Nitric Oxide - antagonists & inhibitors | Analgesics - administration & dosage | Animals | Cyclohexanecarboxylic Acids - pharmacology | Signal Transduction - physiology | Protein Kinase Inhibitors - pharmacology | Nitric Oxide - metabolism | Vasodilator Agents - administration & dosage
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights